triple-negative bc & germline mutations

Options

http://www.medpagetoday.com/MeetingCoverage/ASCO/5...

"The overall mutation prevalence in patients with triple-negative breast cancer was 14.7% compared with 9.2% in patients with other types of breast cancer," reported John Sandbach, MD, of Texas Oncology Austin, and colleagues in a poster presentation at theAmerican Society of Clinical Oncology annual meeting."

Categories